TERN - Terns Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$55.56
DETAILS
HIGH:
$70.00
LOW:
$35.00
MEDIAN:
$56.00
CONSENSUS:
$55.56
UPSIDE:
4.93%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.1 |
| Gross Profit | 0 | 0 | 0 | 0 | 1 | 0 | (0.2) | (0.1) |
| Operating Expenses | ||||||||
| R&D Expenses | 77.9 | 70.1 | 63.5 | 39.6 | 31.3 | 28.0 | 61.5 | 14.6 |
| SG&A Expenses | 32.2 | 31.8 | 39.1 | 22.4 | 19.5 | 9.0 | 8.7 | 3.9 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.0 |
| Operating Expenses | 110.1 | 101.9 | 102.6 | 62.0 | 50.9 | 37.0 | 70.2 | 18.5 |
| Operating Income | ||||||||
| Operating Income | (110.1) | (101.9) | (102.6) | (62.0) | (49.9) | (37.0) | (70.2) | (18.5) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 14.6 | 13.3 | 12.9 | 2.1 | 0.2 | 0.1 | 1.2 | 0.3 |
| Profitability | ||||||||
| EBITDA | (110.1) | (101.0) | (101.7) | (61.0) | (49.3) | (36.6) | (68.6) | (18.4) |
| EBIT | (110.1) | (101.9) | (102.6) | (62.0) | (49.9) | (37.0) | (68.8) | (18.5) |
| Income Before Tax | (95.6) | (88.6) | (90.0) | (60.0) | (49.6) | (29.1) | (68.8) | (18.1) |
| Income Tax Expense | 0.6 | 0.3 | 0.2 | 0.4 | 0.5 | 0.8 | (0.0) | (0.1) |
| Net Income | (96.2) | (88.9) | (90.2) | (60.3) | (50.2) | (29.4) | (68.8) | (17.7) |
| Per Share Data | ||||||||
| EPS (Basic) | -1.03 | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| EPS (Diluted) | -1.03 | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Shares Outstanding | 93.2 | 79.5 | 71.3 | 36.0 | 25.3 | 25.1 | 25.1 | 24.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 524.7 | 161.4 | 79.9 | 143.2 | 47.7 | 74.9 | 12.3 | 82.5 |
| Short-Term Investments | 494.2 | 196.7 | 183.5 | 139.9 | 118.3 | 0 | 7.3 | 4.4 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 12.7 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.2 | 3.9 | 4.0 | 2.1 | 0 | 2.1 | 0.5 | 0.2 |
| Total Current Assets | 1,024.2 | 362.1 | 267.4 | 285.2 | 166.9 | 90.9 | 22.2 | 88.5 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 0.9 | 1.5 | 1.0 | 1.8 | 1.0 | 1.2 | 1.0 | 0.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0.3 | 0.1 | 0.0 | 0.1 | 0.2 | 0.7 | 0.3 |
| Total Non-Current Assets | 0.9 | 1.8 | 1.1 | 1.8 | 1.1 | 1.4 | 1.7 | 0.6 |
| Total Assets | 1,025.1 | 363.9 | 268.5 | 287.0 | 168.1 | 92.3 | 23.9 | 89.1 |
| Current Liabilities | ||||||||
| Account Payables | 1.7 | 2.1 | 2.5 | 1.6 | 2.1 | 0.9 | 1.6 | 0.9 |
| Short-Term Debt | 0 | 0.4 | 0 | 0 | 0 | 12.9 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0.8 | 0 | 0 |
| Other Current Liabilities | 7.4 | 8.4 | 6.0 | 0.2 | 0.4 | 6.7 | 2.1 | 0.1 |
| Total Current Liabilities | 16.4 | 15.7 | 11.9 | 8.5 | 6.8 | 22.8 | 5.0 | 2.4 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.1 |
| Other Non-Current Liabilities | 1.7 | 1.5 | 1.2 | 1.1 | 0.9 | 0.9 | 0.3 | 14.3 |
| Total Non-Current Liabilities | 2.1 | 2.4 | 1.2 | 1.6 | 0.9 | 0.9 | 0.6 | 14.5 |
| Total Liabilities | 18.6 | 18.1 | 13.2 | 10.1 | 7.8 | 23.7 | 5.6 | 16.8 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Retained Earnings | (517.7) | (421.5) | (332.6) | (242.4) | (182.1) | (131.9) | (91.9) | (23.3) |
| Accumulated Other Comprehensive Income | 0.3 | (0.3) | (0.0) | (0.8) | (0.3) | (0.1) | (0.1) | 0.1 |
| Total Stockholders' Equity | 1,006.5 | 345.9 | 255.4 | 276.9 | 160.3 | 68.6 | 4.2 | 72.2 |
| Total Liabilities & Equity | 1,025.1 | 363.9 | 268.5 | 287.0 | 168.1 | 92.3 | 23.9 | 89.1 |
| Debt Metrics | ||||||||
| Total Debt | 0.9 | 1.3 | 0.6 | 1.2 | 0 | 12.9 | 0 | 0 |
| Net Debt | (523.8) | (160.1) | (79.3) | (142.0) | (47.7) | (62.0) | (12.3) | (82.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (96.2) | (88.9) | (90.2) | (60.3) | (50.2) | (40.6) | (68.8) | (18.0) |
| Depreciation & Amortization | 0.5 | 0.9 | 0.9 | 1.0 | 0.5 | 0.4 | 0.2 | 0.1 |
| Stock-Based Compensation | 13.4 | 15.6 | 25.5 | 10.8 | 8.1 | 1.7 | 0.7 | 0.2 |
| Change in Working Capital | (0.3) | 4.4 | 1.5 | (1.0) | (1.4) | 5.1 | 1.9 | (0.4) |
| Other Non-Cash Items | 0.5 | (2.1) | (5.2) | 0.1 | 0.9 | 2.9 | (0.0) | (0.3) |
| Operating Cash Flow | (82.2) | (70.0) | (67.4) | (49.1) | (41.8) | (29.8) | (66.2) | (18.1) |
| Investing Activities | ||||||||
| Capital Expenditure | 0 | (0.0) | (0.1) | (0.3) | (0.3) | (0.6) | (0.9) | (0.2) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.0 |
| Purchases of Investments | (405.0) | (169.9) | (275.8) | (139.7) | (166.3) | (0.7) | (58.4) | (6.9) |
| Sales/Maturities of Investments | 107 | 157.6 | 237.8 | 117.7 | 46.9 | 8.0 | 55.4 | 2.4 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Investing Cash Flow | (298.0) | (12.4) | (38.0) | (22.3) | (119.7) | 6.7 | (3.9) | (4.8) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (12.9) | 16.9 | 0.1 | 0.1 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 1.7 | 0.3 | (0.2) | 10.9 | (0.7) | 0.0 | 12.0 |
| Financing Cash Flow | 743.5 | 164.0 | 42.0 | 167.1 | 134.4 | 85.5 | 0.1 | 99.8 |
| Cash Position | ||||||||
| Net Change in Cash | 363.3 | 81.5 | (63.3) | 95.5 | (27.2) | 62.5 | (70.1) | 77.0 |
| Cash at Beginning | 161.4 | 79.9 | 143.2 | 47.7 | 74.9 | 12.4 | 82.5 | 5.5 |
| Cash at End | 524.7 | 161.4 | 79.9 | 143.2 | 47.7 | 74.9 | 12.4 | 82.5 |
| Free Cash Flow | (82.2) | (70.1) | (67.4) | (49.4) | (42.2) | (30.4) | (67.1) | (18.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 1 | 0 | (0.2) | (0.1) |
| Operating Income | (110.1) | (101.9) | (102.6) | (62.0) | (49.9) | (37.0) | (70.2) | (18.5) |
| Net Income | (96.2) | (88.9) | (90.2) | (60.3) | (50.2) | (29.4) | (68.8) | (17.7) |
| EPS (Diluted) | -1.03 | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 524.7 | 161.4 | 79.9 | 143.2 | 47.7 | 74.9 | 12.3 | 82.5 |
| Total Assets | 1,025.1 | 363.9 | 268.5 | 287.0 | 168.1 | 92.3 | 23.9 | 89.1 |
| Total Debt | 0.9 | 1.3 | 0.6 | 1.2 | 0 | 12.9 | 0 | 0 |
| Stockholders' Equity | 1,006.5 | 345.9 | 255.4 | 276.9 | 160.3 | 68.6 | 4.2 | 72.2 |
| Cash Flow | ||||||||
| Operating Cash Flow | (82.2) | (70.0) | (67.4) | (49.1) | (41.8) | (29.8) | (66.2) | (18.1) |
| Capital Expenditure | 0 | (0.0) | (0.1) | (0.3) | (0.3) | (0.6) | (0.9) | (0.2) |
| Free Cash Flow | (82.2) | (70.1) | (67.4) | (49.4) | (42.2) | (30.4) | (67.1) | (18.3) |